1. Home
  2. TGTX vs VSNT Comparison

TGTX vs VSNT Comparison

Compare TGTX & VSNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$33.79

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

VSNT

Versant Media Group Inc. Class A Common Stock

N/A

Current Price

$39.47

Market Cap

5.3B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
TGTX
VSNT
Founded
1993
2025
Country
United States
United States
Employees
N/A
4400
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.3B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
TGTX
VSNT
Price
$33.79
$39.47
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$49.80
$43.67
AVG Volume (30 Days)
2.1M
2.0M
Earning Date
05-04-2026
05-16-2026
Dividend Yield
N/A
3.87%
EPS Growth
1746.67
N/A
EPS
2.77
N/A
Revenue
$2,785,000.00
N/A
Revenue This Year
$49.08
N/A
Revenue Next Year
$26.69
N/A
P/E Ratio
$12.51
$3.83
Revenue Growth
N/A
N/A
52 Week Low
$25.37
$27.17
52 Week High
$46.48
$38.90

Technical Indicators

Market Signals
Indicator
TGTX
VSNT
Relative Strength Index (RSI) 62.72 71.49
Support Level $33.58 $34.86
Resistance Level $37.11 N/A
Average True Range (ATR) 1.15 1.15
MACD 0.24 0.13
Stochastic Oscillator 72.79 89.20

Price Performance

Historical Comparison
TGTX
VSNT

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.

About VSNT Versant Media Group Inc. Class A Common Stock

Versant Media Group Inc is an independent media company comprised of NBCUniversal's cable television networks, including USA Network, CNBC, MSNBC, Oxygen, SYFY, and Golf Channel, along with complementary digital assets Fandango, Rotten Tomatoes, GolfNow, GolfPass, and SportsEngine.

Share on Social Networks: